MELTZER LESLIE — Chief Research and Development
Insider trading activity for MELTZER LESLIE sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Research and Development
- Company: Apellis Pharmaceuticals, Inc.
- Total insider trades: 8
- Total buy volume: $0
- Total sell volume: $0
- Last trade: May 14, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | SELL | 92,592 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | SELL | 45,220 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | SELL | 61,804 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | SELL | 45,220 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | BUY | 45,220 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | SELL | 22,610 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | BUY | 22,610 | N/A |
| May 14, 2026 | MELTZER LESLIE | APLS Apellis Pharmaceuticals, Inc. | OTHER | 107,024 | N/A |